Spam and phishing mail

No cause for celebration

Spammers were out in force for the USA’s Independence Day, celebrating the country’s diversity in all its glory, and illustrating Jefferson’s thesis that “all men…are endowed…with certain unalienable rights…Life, Liberty, and the pursuit of Happiness”.

First up was spam confirming the predictions of some security companies predicted that cybercriminals would celebrate the holiday with a spam run spreading Waledac (which we detect as Iksmas). What could be more life-affirming than a firework display? Unfortunately, the spam containing links to a fake YouTube video of the 4th July fireworks also pushed malware onto victim machines.

Next, the spammers exhorted recipients to celebrate freedom of choice by paying big bucks to a diploma mill:

And finally, why not pursue happiness by buying drugs online? This message linked to sites selling Xanax, Valium, Oxycontin and other prescription medications.

While you might get a temporary buzz (assuming the products are genuine) you may also find yourself with a nice little drug habit.

What price independence now?

No cause for celebration

Your email address will not be published.



The SessionManager IIS backdoor

In early 2022, we investigated an IIS backdoor called SessionManager. It has been used against NGOs, government, military and industrial organizations in Africa, South America, Asia, Europe, Russia and the Middle East.

APT ToddyCat

ToddyCat is a relatively new APT actor responsible for multiple sets of attacks against high-profile entities in Europe and Asia. Its main distinctive signs are two formerly unknown tools that we call ‘Samurai backdoor’ and ‘Ninja Trojan’.

WinDealer dealing on the side

We have discovered that malware dubbed WinDealer, spread by Chinese-speaking APT actor LuoYu, has an ability to perform intrusions through a man-on-the-side attack.

APT trends report Q1 2022

This is our latest summary of advanced persistent threat (APT) activity, focusing on events that we observed during Q1 2022.

Subscribe to our weekly e-mails

The hottest research right in your inbox